Skip to main content
Log in

Changes of olfactory tract in Parkinson’s disease: a DTI tractography study

  • Functional Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

ABSTRACT

Purpose

Impaired olfactory function is one of the main features of Parkinson’s disease. However, how peripheral olfactory structures are involved remains unclear. Using diffusion tensor imaging fiber tracking, we investigated for MRI microstructural changes in the parkinsonian peripheral olfactory system and particularly the olfactory tract, in order to seek a better understanding of the structural alternations underlying hyposmia in Parkinson’s disease.

Methods

All patients were assessed utilizing by the Italian Olfactory Identification Test for olfactory function and the Unified Parkinson’s Disease Rating Scale-III part as well as Hoehn and Yahr rating scale for motor disability. Imaging was performed on a 3 T Clinical MR scanner. MRI data pre-processing was carried out by DTIPrep, diffusion tensor imaging reconstruction, and fiber tracking using Diffusion Toolkit and tractography analysis by TrackVis. The following parameters were used for groupwise comparison: fractional anisotropy, mean diffusivity, radial diffusivity, axial diffusivity, and tract volume.

Results

Overall 23 patients with Parkinson’s disease (mean age 63.6 ± 9.3 years, UPDRS-III 24.5 ± 12.3, H&Y 1.9 ± 0.5) and 18 controls (mean age 56.3 ± 13.7 years) were recruited. All patients had been diagnosed hyposmic. Diffusion tensor imaging analysis of the olfactory tract showed significant fractional anisotropy, and tract volume decreases for the Parkinson’s disease group compared with controls (P < 0.05). Fractional anisotropy and age, in the control group, were significant for multiple correlations (r = − 0.36, P < 0.05, Spearman’s rank correlation).

Conclusions

Fiber tracking diffusion tensor imaging analysis of olfactory tract was feasible, and it could be helpful for characterizing hyposmia in Parkinson’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5:235–245

    Article  Google Scholar 

  2. Hawkes CH, Del Tredici K, Braak H (2007) Parkinson’s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33:599–614

    Article  CAS  Google Scholar 

  3. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211

    Article  Google Scholar 

  4. Hawkes CH (2008) The prodromal phase of sporadic Parkinson’s disease: does it exist and if so how long is it? Mov Disord 23:1799–1807

    Article  Google Scholar 

  5. Fullard ME, Morley JF, Duda JE (2017) Olfactory dysfunction as an early biomarker in Parkinson’s disease. Neurosci Bull 33:515–525

    Article  CAS  Google Scholar 

  6. Postuma RB, Berg D (2016) Advances in markers of prodromal Parkinson disease. Nat Rev Neurol 12:622–634

    Article  CAS  Google Scholar 

  7. Hummel T, Witt M, Reichmann H, Welge-Luessen A, Haehner A (2009) Immunohistochemical, volumetric, and functional neuroimaging studies in patients with idiopathic Parkinson’s disease. J Neurol Sci 289:119–122

    Article  Google Scholar 

  8. Silveira-Moriyama L, Holton JL, Kingsbury A, Ayling H, Petrie A, Sterlacci W, Poewe W, Maier H, Lees AJ, Revesz T (2009) Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosci Lett 453:77–80

    Article  CAS  Google Scholar 

  9. Del Tredici K, Ru BU, De Vos RA, Bohl JR, Braak H (2002) Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426

    Article  Google Scholar 

  10. Politis M, Wu K, Molloy SG, Bain P, Chaudhuri KR, Piccini P (2010) Parkinson’s disease symptoms: the patient’s perspective. Mov Disord 25:1646–1651

    Article  Google Scholar 

  11. Brooks DJ, Tambasco N (2016) Imaging synucleinopathies. Mov Disord 31:814–829

    Article  Google Scholar 

  12. Su M, Wang S, Fang W, Zhu Y, Li R, Sheng K, Zou D, Han Y, Wang X, Cheng O (2015) Alterations in the limbic/paralimbic cortices of Parkinson’s disease patients with hyposmia under resting-state functional MRI by regional homogeneity and functional connectivity analysis. Parkinsonism Relat Disord 21(7):698–703

    Article  Google Scholar 

  13. Scherfler C, Schocke MF, Seppi K, Esterhammer R, Brenneis C, Jaschke W, Wenning GK, Poewe W (2006) Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson’s disease. Brain 129:538–542

    Article  Google Scholar 

  14. Zhang K, Yu C, Zhang Y, Wu X, Zhu C, Chan P, Li K (2011) Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson’s disease. Eur J Radiol 77:269–273

    Article  Google Scholar 

  15. Ibarretxe-Bilbao N, Junque C, Marti MJ, Valldeoriola F, Vendrell P, Bargallo N, Zarei M, Tolosa E (2010) Olfactory impairment in Parkinson’s disease and white matter abnormalities in central olfactory areas: a voxel-based diffusion tensor imaging study. Mov Disord 25:1888–1894

    Article  Google Scholar 

  16. Basser PJ, Mattiello J, LeBihan D (1994) MR diffusion tensor spectroscopy and imaging. Biophys J 66:259–267

    Article  CAS  Google Scholar 

  17. Alexander AL, Lee JE, Lazar M, Field AS (2007) Diffusion tensor imaging of the brain. Neurotherapeutics 4:316–329

    Article  Google Scholar 

  18. Abhinav K, Yeh FC, Pathak S, Suski V, Lacomis D, Friedlander RM, Fernandez-Miranda JC (2014) Advanced diffusion MRI fiber tracking in neurosurgical and neurodegenerative disorders and neuroanatomical studies: a review. Biochim Biophys Acta 1842:2286–2297

    Article  CAS  Google Scholar 

  19. Schulte T, Sullivan EV, Müller-Oehring EM, Adalsteinsson E, Pfefferbaum A (2005) Corpus callosal microstructural integrity influences interhemispheric processing: a diffusion tensor imaging study. Cereb Cortex 15:1384–1392

    Article  CAS  Google Scholar 

  20. Skorpil M, Rolheiser T, Robertson H, Sundin A, Svenningsson P (2011) Diffusion tensor fiber tractography of the olfactory tract. Magn Reson Imaging 29:289–292

    Article  Google Scholar 

  21. Daniel SE, Lees AJ (1993) Parkinson’s Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 39:165–172

    CAS  PubMed  Google Scholar 

  22. Maremmani C, Rossi G, Tambasco N, Fattori B, Pieroni A, Ramat S, Napolitano A, Vanni P, Serra P, Piersanti P, Zanetti M, Coltelli M, Orsini M, Marconi R, Purcaro C, Rossi A, Calabresi P, Meco G (2012) The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson’s disease patients. Parkinsonism Relat Disord 18:788–793

    Article  Google Scholar 

  23. Rl D, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 55:128–142 20

    Article  Google Scholar 

  24. Scherfler C, Esterhammer R, Nocker M, Mahlknecht P, Stockner H, Warwitz B, Spielberger S, Pinter B, Donnemiller E, Decristoforo C, Virgolini I, Schocke M, Poewe W, Seppi K (2013) Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson’s disease. Brain 136:3028–3037

    Article  Google Scholar 

  25. Oguz I, Farzinfar M, Matsui J, Budin F, Liu Z, Gerig G, Johnson HJ, Styner M (2014) DTIPrep: quality control of diffusion-weighted images. Front Neuroinform 8:4

    Article  Google Scholar 

  26. Wang R, Benner T, Sorensen AG et al (2007) Diffusion toolkit: a software package for diffusion imaging data processing and tractography. Proc Intl Soc Mag Reson Med 15:3720

    Google Scholar 

  27. Atkinson-Clement C, Pinto S, Eusebio A, Coulon O (2017) Diffusion tensor imaging in Parkinson’s disease: review and meta-analysis. NeuroImage Clin 16:98–110

    Article  Google Scholar 

  28. Rolheiser TM, Fulton HG, Good KP, Fisk JD, McKelvey JR, Scherfler C, Khan NM, Leslie RA, Robertson HA (2011) Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson’s disease. J Neurol 258:1254–1260

    Article  Google Scholar 

  29. Chen NK, Chou YH, Sundman M, Hickey P, Kasoff WS, Bernstein A, Trouard TP, Lin T, Rapcsak SZ, Sherman SJ, Weingarten CP (2018) Alteration of diffusion-tensor magnetic resonance imaging measures in brain regions involved in early stages of Parkinson’s disease. Brain Connect 8:343–349

    Article  Google Scholar 

  30. Nigro S, Riccelli R, Passamonti L, Arabia G, Morelli M, Nisticò R, Novellino F, Salsone M, Barbagallo G, Quattrone A (2016) Characterizing structural neural networks in de novo Parkinson disease patients using diffusion tensor imaging: altered structural brain network in drug-Naïve PD. Hum Brain Mapp 37:4500–4510

    Article  CAS  Google Scholar 

  31. Dando SJ, Mackay-Sim A, Norton R, Currie BJ, St John JA, Ekberg JA, Batzloff M, Ulett GC, Beacham IR (2014) Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev 27:691–726

    Article  Google Scholar 

  32. Doty RL (2008) The olfactory vector hypothesis of neurodegenerative disease: is it viable? Ann Neurol 63:7–15

    Article  Google Scholar 

  33. Rey NL, Wesson DW, Brundin P (2018) The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis 109:226–248

    Article  CAS  Google Scholar 

  34. Aguzzi A, Baumann F, Bremer J (2008) The Prion’s elusive reason for being. Annu Rev Neurosci 31:439–477

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The Movement Disorders Center of the University of Perugia was supported by a grant from the New York University School of Medicine and the Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders, which was made possible with support from Marlene and Paolo Fresco.

Funding

No funding was received for this study.

Author information

Authors and Affiliations

Authors

Contributions

All authors have approved the final article.

Corresponding author

Correspondence to Nicola Tambasco.

Ethics declarations

Conflict of interest

NT received a travel grant from Abbvie. PaC received research support from Bayer Schering, Biogen-Dompé, Boehringer Ingelheim, Eisai, Lundbeck, Merck-Serono, Novartis, Sanofi-Aventis, Sigma-Tau, and UCB Pharma. PN, AC, PE, SS, FPP, GC, PC, MF, RT, GG, VS, and LP declare that there are no disclosures to report.

Ethical approval

The study was reviewed and approved by the local ethic committee.

Informed consent

After a full explanation of the study, written informed consent was obtained from all participants according to the Declaration of Helsinki.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nigro, P., Chiappiniello, A., Simoni, S. et al. Changes of olfactory tract in Parkinson’s disease: a DTI tractography study. Neuroradiology 63, 235–242 (2021). https://doi.org/10.1007/s00234-020-02551-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-020-02551-4

Keywords

Navigation